Introduction

Inflammatory bowel disease (IBD) is a recurrent inflammatory disease characterized by uncontrollable inflammation of the intestinal mucosa

Traditional IBD treatments include 5-aminosalicylic acid (5-ASA), corticosteroids (CS), Janus kinase inhibitors, anti-tumor necrosis factor-α (anti-TNF-α), antibodies, and surgery

Figure 1 Metabolism of resveratrol in the human body

Figure 2 Potentially related signaling pathways that resveratrol regulates IBD

Resveratrol and its derivates improve inflammatory bowel disease by targeting gut microbiota and inflammatory signaling pathways

Ming Li, Ping Li, Rongxue Tang, Hui Lu ^*

State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China

*Corresponding author.

E-mail address: 402313318059@email.

Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory lesion of the intestine, mainly manifested by infiltration of intestinal inflammatory cells and imbalance of gut microbiota.